Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | EVP, GC, Corporate Secretary | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-02-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-25 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2026-02-25 · Sale · Disposed 20,000 · Balance 0 F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person. |
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $43.58 · Expires 2029-01-22 | Direct | 20,000 |
Reported balance
After 2026-02-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-25 · Exercise / conversion · Disposed 20,000 · Balance 20,000 F2: These options were granted on January 22, 2019 and are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated November 12, 2025 executed by the reporting person.
F2: These options were granted on January 22, 2019 and are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2019 Filed Dec 19, 2019 21:38 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 3,076 | $11.86 | $36,481.36 |
DisclosureSEC source: 0001209191-19-061307 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $55.90 | $167,700.00 |
DisclosureSEC source: 0001209191-19-056034 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,384 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:31 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $52.90 | $158,700.00 |
DisclosureSEC source: 0001209191-19-054904 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,384 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| August 02, 2019 Filed Aug 29, 2019 21:00 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $49.90 | $149,700.00 |
DisclosureSEC source: 0001209191-19-047725 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,384 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:47 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $48.59 | $145,770.00 |
DisclosureSEC source: 0001209191-19-022014 · doc4.xml · nonDerivative · entry 1 Huller Kelly · CIK 0001768417 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,384 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.